BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9529134)

  • 1. Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements.
    Andreasson P; Johansson B; Billström R; Garwicz S; Mitelman F; Höglund M
    Leukemia; 1998 Mar; 12(3):390-400. PubMed ID: 9529134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2.
    Höglund M; Johansson B; Pedersen-Bjergaard J; Marynen P; Mitelman F
    Blood; 1996 Jan; 87(1):324-30. PubMed ID: 8547659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities.
    Andreasson P; Johansson B; Arheden K; Billström R; Mitelman F; Höglund M
    Genes Chromosomes Cancer; 1997 Jun; 19(2):77-83. PubMed ID: 9171997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of the ETV6 gene occur in the majority of patients with aberrations of the short arm of chromosome 12: a combined PCR and Southern blotting analysis.
    O'Connor HE; Butler TA; Clark R; Swanton S; Harrison CJ; Secker-Walker LM; Foroni L
    Leukemia; 1998 Jul; 12(7):1099-106. PubMed ID: 9665196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic characterization of breakpoints in 19 patients with hematologic malignancies and 12p unbalanced translocations.
    Odero MD; Carlson K; Lahortiga I; Calasanz MJ; Rowley JD
    Cancer Genet Cytogenet; 2003 Apr; 142(2):115-9. PubMed ID: 12699886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies.
    Wlodarska I; Marynen P; La Starza R; Mecucci C; Van den Berghe H
    Cytogenet Cell Genet; 1996; 72(2-3):229-35. PubMed ID: 8978784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
    Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
    Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetic characterization of rearrangements involving 12p in leukemia.
    Vieira L; Marques B; Cavaleiro C; Ambrósio AP; Jorge M; Neto A; Costa JM; Júnior EC; Boavida MG
    Cancer Genet Cytogenet; 2005 Mar; 157(2):134-9. PubMed ID: 15721634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of myeloid disorders and a t(8;12) (q12;p13).
    Hernández JM; González MB; García JL; Ferro MT; Gutiérrez NC; Marynen P; San Miguel JF
    Haematologica; 2000 Jan; 85(1):31-4. PubMed ID: 10629588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.
    Sato Y; Suto Y; Pietenpol J; Golub TR; Gilliland DG; Davis EM; Le Beau MM; Roberts JM; Vogelstein B; Rowley JD
    Blood; 1995 Aug; 86(4):1525-33. PubMed ID: 7632960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
    Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
    Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies.
    Johansson B; Arheden K; Höglund M; Othzén A; Békássy AN; Turesson I; Heim S; Mitelman F
    Genes Chromosomes Cancer; 1995 Sep; 14(1):56-62. PubMed ID: 8527385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.
    Haferlach C; Bacher U; Kohlmann A; Schindela S; Alpermann T; Kern W; Schnittger S; Haferlach T
    Haematologica; 2011 Jun; 96(6):829-36. PubMed ID: 21422114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia.
    Cavé H; Cacheux V; Raynaud S; Brunie G; Bakkus M; Cochaux P; Preudhomme C; Laï JL; Vilmer E; Grandchamp B
    Leukemia; 1997 Sep; 11(9):1459-64. PubMed ID: 9305598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
    Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
    Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 12p molecular events outside ETV6 in complex karyotypes of acute myeloid malignancies.
    La Starza R; Stella M; Testoni N; Di Bona E; Ciolli S; Marynen P; Martelli MF; Mandelli F; Mecucci C
    Br J Haematol; 1999 Nov; 107(2):340-6. PubMed ID: 10583222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies.
    Wlodarska I; La Starza R; Baens M; Dierlamm J; Uyttebroeck A; Selleslag D; Francine A; Mecucci C; Hagemeijer A; Van den Berghe H; Marynen P
    Blood; 1998 Feb; 91(4):1399-406. PubMed ID: 9454771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies.
    Dreyling MH; Bohlander SK; Le Beau MM; Olopade OI
    Blood; 1995 Sep; 86(5):1931-8. PubMed ID: 7544647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal instability in chromosome band 12p13: multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clones.
    Sato Y; Kobayashi H; Suto Y; Olney HJ; Davis EM; Super HG; Espinosa R; Le Beau MM; Rowley JD
    Leukemia; 2001 Aug; 15(8):1193-202. PubMed ID: 11480561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.